Domain experts often rely on up-to-date knowledge for apprehending and disseminating specific biological processes that help them design strategies to develop prevention and therapeutic decision-making. A challenging scenario for artificial intelligence (AI) is using biomedical data (e.g., texts, imaging, omics, and clinical) to provide diagnosis and treatment recommendations for cancerous conditions. Data and knowledge about cancer, drugs, genes, proteins, and their mechanism is spread across structured (knowledge bases (KBs)) and unstructured (e.g., scientific articles) sources. A large-scale knowledge graph (KG) can be constructed by integrating these data, followed by extracting facts about semantically interrelated entities and relations. Such KGs not only allow exploration and question answering (QA) but also allow domain experts to deduce new knowledge. However, exploring and querying large-scale KGs is tedious for non-domain users due to a lack of understanding of the underlying data assets and semantic technologies. In this paper, we develop a domain KG to leverage cancer-specific biomarker discovery and interactive QA. For this, a domain ontology called OncoNet Ontology (ONO) is developed to enable semantic reasoning for validating gene-disease relations. The KG is then enriched by harmonizing the ONO, controlled vocabularies, and additional biomedical concepts from scientific articles by employing BioBERT- and SciBERT-based information extraction (IE) methods. Further, since the biomedical domain is evolving, where new findings often replace old ones, without employing up-to-date findings, there is a high chance an AI system exhibits concept drift while providing diagnosis and treatment. Therefore, we finetuned the KG using large language models (LLMs) based on more recent articles and KBs that might not have been seen by the named entity recognition models.

翻译：暂无翻译